|
1.
Share Success: Letters From Readers
Letter I: From Sharon P.
Received
at Testimonial Submit Form Thursday, Sep 26, 2019 at 11:09 AM
(Unedited)
Hi, my name is Sharon P.
Just received my test results from my bone scan--very happy with the results.
My scores have increased by three percent. I was diagnosed with osteoporosis and now back in the pina category. Doctor said to keep up the calcium intake.
My blood pressure has now stabilized also with no white coat syndrome. Your supplement marvlix did a wonderful job of stabilizing me.
I am 77 years old and feel great--its been one year and what an improvement.
Thanks,
Sharon
Letter II: From Cynthia C.
Received
at sharesuccess @ ezorbonline.com Oct 2, 2019 at 9:22 AM
(Unedited)
Dear friends at EZorb,
I've been taking your Calcium Aspartate Anhydrous supplements for a year and am happy.
I have osteoporosis and a new puppy, a dangerous combo. While she has pulled me down several times, I have not broken any bones which is miraculous since I've broken several bones in recent years.
For the first three months I was taking the larger dosage and now have pulled back slightly as was recommended.
It seems to be working as my puppy pulls me around quite a bit and I've taken some nasty falls but no fractures. Thanks so much!
Cindy
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 120,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Lower Back Pain May Increase Fall Risk in Knee OA Patients
Researchers have identified an association between the presence of moderate-to-severe low back pain (LBP) and risk for falls among patients with knee osteoarthritis (OA).
Among 189 community-dwelling adults aged an average of 74 years, the 45 who reported having moderate-to-severe LBP were significantly more likely to have experienced at least one fall in the preceding year than those without moderate-to-severe LBP, at rates of 37.8% and 16.6%, respectively.
The proportion of patients experiencing at least two falls was also higher among those with versus without moderate-to-severe LBP, at 26.7% versus 8.3%.
After adjustment for factors including age, sex, knee pain, and quadriceps muscle strength, these findings translated into a 2.9-fold higher risk for any falls, and a 3.7-fold higher risk for two or more falls, among people with moderate-to-severe LBP, report Hirotaka Iijima (Keio University, Yokohama, Japan) and team.
Noting that fall rates were numerically, but not significantly, higher among patients with any LBP compared with those without, the researchers say that "LBP severity may be a crucial factor for recurrent falls."
They conclude in Arthritis Care & Research that future studies should "determine the causality [of the associations shown] and ascertain the effectiveness of therapeutic interventions for LBP for the prevention of falls in people with knee OA."
Original article was published in Arthritis Care Res 2020; doi:10.1002/acr.24136.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
